Hepatitis C with normal liver enzymes: to treat or not to treat. Pro: most patients should be treated

Am J Gastroenterol. 2004 Jun;99(6):972-3. doi: 10.1111/j.1572-0241.2004.40510.x.
No abstract available

Publication types

  • Comparative Study
  • Review

MeSH terms

  • Alanine Transaminase / analysis*
  • Antiviral Agents / therapeutic use*
  • Decision Making
  • Drug Therapy, Combination
  • Female
  • Hepatitis C, Chronic / diagnosis*
  • Hepatitis C, Chronic / drug therapy*
  • Hepatitis C, Chronic / epidemiology
  • Humans
  • Incidence
  • Interferon alpha-2
  • Interferon-alpha / administration & dosage
  • Liver Function Tests
  • Male
  • Prognosis
  • Recombinant Proteins
  • Reference Values
  • Ribavirin / therapeutic use
  • Risk Assessment
  • Severity of Illness Index
  • United States / epidemiology

Substances

  • Antiviral Agents
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Ribavirin
  • Alanine Transaminase